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Astrocytes participate in information processing by actively modulating
synapticpropertiesviagliotransmitter release.Variousmechanismsof astrocytic
release have been reported, including release from storage organelles via exocy-
tosis and release from the cytosol via plasma membrane ion channels and
pumps. It is still not fully clear which mechanisms operate under which con-
ditions, but some of them, being Ca2þ-regulated, may be physiologically
relevant. The properties of Ca2þ-dependent transmitter release via exocytosis
or via ion channels are different and expected to produce different extracellular
transmitter concentrations over time and to have distinct functional conse-
quences. The molecular aspects of these two release pathways are still under
active investigation. Here, we discuss the existingmorphological and functional
evidence in support of either of them. Transgenicmousemodels, specific antag-
onists and localization studies have provided insight into regulated exocytosis,
albeit not in a systematic fashion. Evenmore remains to be uncovered about the
details of channel-mediated release. Better functional tools and improved ultra-
structural approaches are needed in order fully to define specificmodalities and
effects of astrocytic gliotransmitter release pathways.1. Introduction
The importance of astrocytes in brain function is increasingly appreciated. In
addition to providing homeostatic control and metabolic support, they play an
active role in information processing within neuronal circuits [1,2]. As part of the
bi-directional communication, astrocytes canboth receive andsend chemical signals
to neurons. Numerous studies have shown that astrocytes can respond to various
neurotransmitters and factors and in turn release glutamate, D-serine, ATP, and
gamma-aminobutyric acid (GABA) as well as prostaglandins and neuropeptides
in a process termed gliotransmission (for some recent reviews, see [3,4]).
Various mechanisms have been proposed for such gliotransmission, including
Ca2þ-regulated vesicular exocytosis and non-vesicular release. Non-vesicular
release may be achieved via plasma membrane ion channels, such as connexin/
pannexin hemichannels, purinergic P2X7 channels, volume-regulated anion
channels and via pumps, such as the glutamate–cysteine exchanger or the glu-
tamate uptake system working in reverse [3]. So far, there is no clear evidence
that channel-mediated (connexins/pannexins/P2X7) mechanisms are relevant to
physiological communication between astrocytes and neurons, because opening
of the channels was shown to occur mainly under non-physiological conditions
such as traumatic injury, seizure activity and altered oxygen and glucose concen-
trations [5,6]. In view of this, Ca2þ-dependent exocytosis has been proposed as the
major mechanism for release of themain gliotransmitters (glutamate, D-serine and
ATP), similar towhat happens in neurons and secretory cells. More recently, how-
ever, an anion channel, Bestrophin-1 (Best-1), has been reported to play a role in
GABA and glutamate release from astrocytes under physiological conditions
[7,8]. Furthermore, a very fast (milliseconds) but Ca2þ-independent release of
glutamatewas reported via the potassium channel TREK-1 [8]. It is, however, pres-
ently not clear how a channel structurally devised to selectively flux a small cation
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Figure 1. Two modes (vesicular and channel-mediated) of glutamate release detected by sniffer cells. (a) Schematic diagram of the sniffer cell experiments; astrocytes
stimulated by receptor agonists; sniffer cells expressing transfected ionotropic glutamate receptors. (b) Astrocytic activation by the application of the AMPAR/mGluR agonist
L-quisqualate (red arrowhead) triggers a rapid burst of excitatory post-synaptic currents (EPSCs) in an N-methyl-D-aspartate (NMDA) receptor-expressing HEK ‘sniffer’ cell.
These EPSCs are thought to reflect quantal events of vesicular glutamate release from the astrocyte (adapted with permission from [13], fig. 3b). (c) Application of a TFLLR
agonist of the PAR-1 metabotropic receptors (arrowhead) to astrocytes triggers a slow current in HEK cells expressing non-desensitizing a-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors. This current is thought to be mediated by glutamate release through anion channel Best-1 and disappears in Best-1 knockout or
knock-down astrocytes (adapted with permission from [8], sniffer experiments on a cultured astrocyte transfected with TREK-1 shRNA, fig. 2i).
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2such as Kþ can adapt to release a negatively charged andmuch
bigger organic anion such as glutamate. In conclusion, whether
regulated exocytosis or a channel-mediated mechanism (or
both) is responsible for gliotransmission under physiological
conditions presently remains a topic of active debate [3,9].
Neither the molecular mechanisms of gliotransmitter
release, nor their regulation are yet fully understood. However,
Ca2þ is believed to be the main regulator of gliotransmission.
Transient rises in intracellular Ca2þ concentration have been
observed upon astrocyte stimulation in situ and in vivo and
often shown to be important for gliotransmitter release. For
some recent reviews on the role and sources of Ca2þ in astro-
cytes, see e.g. [1,10], but also see [11,12]. In this review, we
shall focus on the downstream effects of Ca2þ on gliotrans-
mission. In particular, we will discuss vesicular exocytosis
and Best-1 channel release because both these pathways are
Ca2þ-dependent and putatively physiologically relevant.2. Regulated exocytosis and release via channels
from astrocytes
Gliotransmitters may be released from a storage compartment
via exocytosis, or directly from the cytosol via plasma mem-
brane ion channels. In theory, release through membrane
channels or transporters would be energetically ‘cheaper’
than transporting and pre-concentrating a transmitter insidea secretory compartment, often against a steeper electrochem-
ical gradient. However, the nature of channel release has other
limitations, namely that a large amount of transmitter cannot
be released all at once (as it can be by pre-concentrating it
inside a vesicle). Instead, smaller amounts of transmitter may
be released per unit time, but on a much longer timescale. As
such, temporal precision and maximum peak concentrations
are sacrificed. The two mechanisms may, therefore, have
different functional consequences (see figure 1).
Regulated exocytosis in neurons is triggered when an action
potential (AP) reaches the nerve terminals and evokes a local
Ca2þ increase that, in turn, triggers rapid (less than amillisecond)
soluble NSF attachment protein (SNAP) receptor (SNARE)-
dependent fusion of release-ready synaptic vesicles (SVs) with
the plasma membrane. AP-dependent synaptic release relies on
the interaction of the SNARE proteins, VAMP2, Syntaxin 1 and
SNAP25, as well as other regulatory proteins including the
Ca2þ sensor, such as synaptotagmin I [14]. In astrocytes, earlier
studies in cultures have suggested that they likewise express
VAMP2, raising the question of whether astrocytes are also
competent for regulated exocytosis [15].
Release from the cytosol via plasma membrane ion chan-
nels does not directly require a SNARE-mediated fusion
event. However, channel trafficking and insertion into the
plasma membrane may still involve Ca2þ changes and
SNARE proteins, albeit in general on a much longer timescale
compared with regulated exocytosis. It can take hundreds of
Box 1. Genetic mouse models to study regulated exocytosis from astrocytes.
So far the use of genetic mouse models for testing the physiological relevance of Ca2þ-dependent exocytosis from astrocytes
has been aimed at interfering with SNARE proteins required for regulated exocytosis. Two models were created, namely the
dominant negative (dn)SNARE mouse, which overexpresses VAMP2 lacking its transmembrane domain in GFAP-positive
cells in a doxycycline-inducible manner [25], and the ‘iBot’ mouse, which expresses clostridial botulinum neurotoxin serotype
B light chain (BoNT/B) in GLAST-positive astrocytes using the inducible Cre/loxP system [26]. The dnSNARE mouse has the
goal to prevent VAMP2-dependent exocytosis specifically in astrocytes by outcompeting endogenous VAMP2, and hence to
block VAMP2-dependent fusion events. Similarly, the ‘iBot’ mouse is meant to prevent exocytosis by overexpressing specifi-
cally in astrocytes active BoNT/B which cleaves and inactivates VAMPs 2 and 3 [22,27]. It should be noted that while VAMP2
has been described as being present in astrocytic cultures [15,28], it appears to be low or absent in the adult hippocampal
astrocytes in situ [29]. Instead, astrocytes express VAMP3 at high levels [29–31]. It is known that VAMPs can participate
in the formation of several different SNARE complexes by pairing with more than one set of partners [32]. In view of
this, VAMP3-dependent fusion is still likely to be disrupted in the dnSNARE mouse. However, because VAMP3 is also
involved in constitutive protein trafficking, it is unclear whether other VAMP3-dependent fusion events would be affected
in the dnSNARE mouse. Moreover, since the dnSNARE mouse is activated by doxycycline treatment over several weeks,
compensatory mechanisms may occur.
To date, the dnSNARE mouse has been used in multiple studies, providing the important demonstration that SNARE-
dependent pathway(s) in astrocytes are critically involved in several physiological and pathological processes, including
sleep, inflammation, drug-seeking behaviour or stroke [33–35]. While this mouse has been used for in vivo and behavioural
studies, it has not fully provided detailed mechanistic insight so far. For example, biosensor studies have suggested that over-
expression of the dnSNARE domain results in changes in extracellular adenosine levels [36] but have been less clear
concerning extracellular glutamate or D-serine [37]. This is possibly due to the low sensitivity of the biosensor approach
in situ or in vivo, particularly with respect to extracellular glutamate detection. Indeed, strong expression of high-affinity glu-
tamate transporters in the tissue makes likely that any released glutamate is rapidly taken up before being detected by the
sensor, unless the location of release is targeted precisely.
Similar concerns have been raised regarding the newer ‘iBot’ mouse model, which has not been as widely used to date.
Here, both VAMP2 and VAMP3 should be inactivated by the protease activity of the toxin, but it is not clear how efficiently
this occurs in astrocytes in situ. In particular, it is not known whether sufficient levels of the toxin are expressed in all astro-
cytes, and whether the toxin is active over time. Unfortunately, the crucial experiment designed to show whether VAMP2 and
3 are cleaved efficiently in astrocytes and retinal Mueller cells in vivo [26] is not clear since the protease activity was not prop-
erly demonstrated. As with the dnSNARE mouse, specificity can be also an issue, because the cytoplasmic expression of
BoNT/B will target all VAMP3-dependent fusion events, including possibly constitutive exocytosis.
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3seconds to insert a channel into the membrane after a stimulus
(see e.g. AMPA receptors [16]).(a) Functional evidence for regulated vesicular
exocytosis in astrocytes
To examine whether regulated exocytosis is the mechanism
underlying the modulatory actions of astrocytes in synaptic
function and plasticity, several approaches have been taken.
First, the releasewas shown tobe Ca2þ-dependent, because infu-
sion of Ca2þ buffer solutions in astrocytes led to perturbation of
synaptic activity [17–20]. However, this approach per se is insuf-
ficient to identify exocytosis as the mechanism of the release
because channel opening can also be controlled by Ca2þ [8,21].
Therefore, the mechanism was probed further using tetanus or
botulinum toxins that cleave VAMP2/3 or SNAP 23/25 selec-
tively, and which were shown to block regulated exocytosis in
neurons [22]. By putting the membrane-impermeant light
chain fragment of tetanus toxin (TeNTLC) inside astrocytes, the
synaptic effects of gliotransmission were blocked [17,19,23,24].
Additionally, two mouse models, dubbed ‘dnSNARE’ and
‘iBot’, were generated to interfere specifically with VAMP2 and
3 in astrocytes (see box 1). Use of the above mice has generally
resulted in the perturbation of synaptic properties of the neur-
onal circuit and suggested that VAMP2 or 3-dependent
exocytosis from astrocytes was involved.However, dependency of the release on SNAREs and Ca2þ
is still not sufficient proof that gliotransmitter release is
achieved via regulated exocytosis because SNARE proteins
and Ca2þ may be equally important for insertion of plasma
membrane-bound ion channels (such as Best-1) or pumps [3],
although the latter process is much slower. Therefore, to inves-
tigate the mechanism further, attempts were made to interfere
with other aspects critical for exocytic release such as vesicular
uptake of transmitter or to determine the speed of release.
Here, the results obtained for the main gliotransmitters,
D-serine, ATP and glutamate are summarized:
(i) D-serine
The release of D-serine from astrocytes in the CA1 region of the
hippocampus was shown to be important for long-term poten-
tiation (LTP) at Schaffer collateral–pyramidal cell synapses.
Experiments indicated that this form of LTP is disrupted by
selective infusion of astrocytes with TeNTLC or ‘Ca
2þ clamp’
solution [19] (but see [38]). Importantly, by blocking D-serine
production inside the astrocytewith the serine racemace inhibi-
tor HOAsp, it was demonstrated that D-serine can nevertheless
remain stored for prolonged periods in a putative astrocytic
compartment. Moreover, this D-serine pool was depleted by
pre-stimulation experiments, leading to the abolition of LTP
[19]. These observations support a vesicular rather than a chan-
nel-mediated mode of D-serine release from astrocytes during
LTP induction.
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4(ii) ATP
The dnSNAREmousemodelwas used extensively to investigate
ATP release from astrocytes [25]. In several studies using this
model, ATP release was generally reduced, but temporal infor-
mation was hard to obtain (see details in box 1). However, a
recent study was able to observe exocytosis of astrocytic ATP in
thecortexdirectly, bymonitoringquantal releaseontoP2X4neur-
onal receptors [39]. ATP releasewas detectedwithin hundreds of
milliseconds from astrocytic activation and corresponding Ca2þ
increase. The detected ATP events were quantally distributed,
suggesting that a storage compartment is involved [39].
(iii) Glutamate
One approach to study glutamate release from astrocytes has
focused on the presence and function of vesicular glutamate
transporters (vGluts) in these cells. Currently available vGlut
antagonists (e.g.EvansBlueandRoseBengal) arepoorlyselective.
Nevertheless, experiments using these agents in tissue have pro-
duced intriguing results. Infusing the astrocytes with Evans
Bluehas abolished spike-timing-dependent long-termdepression
(LTD) at nearby synapses in the cortex [24]. The same effect was
obtained by patching the astrocytes with a ‘Ca2þ clamp’ or with
TeNTLC. All these results are consistent with a vesicular nature
of the astrocytic release [24], at least in this preparation.
In the hippocampal dentate gyrus, glutamate release from
astrocytes was shown to activate pre-synaptic NMDARs and
thereby increase transmitter release probability at nearby per-
forant path–granule cell synapses [20,23]. Astrocytes were
stimulated electrically and the changes in synaptic release
(e.g. changes in miniature (m)EPSC frequency) were monitored
[23]. The increase in synaptic release probability occurred
within seconds of astrocytic stimulation and was blocked by
prior infusion of astrocytes with the Ca2þ chelator BAPTA
[20,23] or with TeNTLC but not of a non-functional mutant ver-
sion of the toxin. Because the astrocyte-evoked synaptic effect
was fast (approximately in seconds) and Ca2þ and SNARE
dependent [23], it was concluded that glutamate was released
by regulated exocytosis in this system. Similarly, fast (approx.
10 s) modulation of neuronal release by astrocytic glutamate
was observed at immature GABAergic synapses [40,41].
(b) Functional evidence for channel-mediated
gliotransmitter release
Besides regulated exocytosis, gliotransmitter release may
occur directly from the cytosol by flux across plasma mem-
brane ion channels. Regulated release through membrane
channels in astrocytes is possible because these cells are
known to express a large variety of anion channels (for
reviews, see e.g. [42]), including Ca2þ-dependent Cl2 chan-
nels [43]. Anion channels generally tend to be promiscuous,
allowing flux of both small inorganic anions such as Cl2,
as well as larger anions such as hydrocarbonate, GABA,
glutamate, taurine and L-aspartate. For example, release of
taurine from astrocytes via volume-regulated anion channels
plays a significant physiological role in modulating neuronal
firing by releasing taurine in osmosensitive areas of the
hypothalamus [44]. Release of glutamate via Ca2þ-regulated
channels was reported in tissue several years ago, although
the molecular identity of the anion channel was not estab-
lished at that time [21]. More recently, the anion channel
Best-1 has been shown to function in GABA releasefrom cerebellar glia [7] and in glutamate release from astro-
cytes in the CA1 of the hippocampus [8,45]. What are the
properties of glutamate and GABA release via a channel?
Best-1 conductance was shown to be Ca2þ-dependent by
patch-clamping cells using internal solutions containing a
range of free Ca2þ concentrations, but its conductance can
also be stretch (osmolarity) dependent [46]. Whether Best-1
directly senses Ca2þ or is modulated by an intermediary
Ca2þ-sensitive protein is unclear. It has been proposed that
Best-1 can directly sense Ca2þ via a Ca2þ-binding domain
that can modulate channel opening [47]. A separate form of
Best-1 regulation is via phosphorylation [48].
In a culture system or in acutely dissociated astrocytes, it has
been shown that glutamate release through Best-1 is relatively
slow. The delay between astrocytic stimulation (by puffing
an agonist of the protease activator receptor PAR-1) and the
resulting glutamate detection in sniffer cells expressing an engin-
eeredAMPAreceptor is in the orderof 10–20 s [8]. By contrast, in
a comparable system, regulated exocytosis in astrocytes can be
much more rapid. In culture, astrocytic vGlut2-GFP- or vGlut1-
pHluorin-positive vesicles were reported to fuse within tens of
milliseconds of receiving a stimulus, such as aGprotein-coupled
receptor (GPCR) agonist [30,49], which is nearly three orders of
magnitude faster than the Best-1 channel-mediated release.
In a recent study, itwas concluded that Best-1-mediated glu-
tamate release is TeNT insensitive [8]. This was despite a
reported reduction in the sniffer cell AMPA receptor currents
within 20 min of the astrocytes being patchedwith a TeNT-con-
taining solution. This reduction was attributed to a ‘side-effect’
of the toxin, exiting the astrocyte and inhibiting the sniffer cell
receptor expression on the cell surface [8]. However, it is not
clearwhether the holotoxin TeNT (which can crossmembranes)
or TeNTLC (which cannot cross membranes) was used in these
experiments. In keeping, a prior report of glutamate release
through an anion channel which used an enzymatic assay
rather than the sniffer cell assay, showed no sensitivity to
TeNT even after 24 h incubation with the toxin [21]. These
data would suggest that the turnover of Best-1 insertion at the
plasma membrane is extremely slow.
(c) Morphological evidence for gliotransmitter release
from a storage compartment
In contrast to the ion channel-mediated mode of release for
which channels should be localized at the plasma membrane,
Ca2þ-regulated exocytosis relies on a dedicated compartment
that stores gliotransmitters. This needs to be equipped with a
transporter that pumps the gliotransmitter into the compart-
ment, as well as with the proteins that mediate and regulate
the fusion event. There is no doubt that astrocytes contain
tubular-vesicular structures as part of the endocytic and exo-
cytic pathway (see box 2) but is there a compartment
competent for regulated exocytosis of gliotransmitters?
Inastrocytic cultures, several compartmentshavebeenshown
to undergo regulated exocytosis, including a vesicular compart-
ment termed small synaptic-like microvesicles (SLMVs),
secretory lysosomes and dense core granules [30,61,62]. For
example, ATP has been shown to be released from secretory
lysosomes [63,64].However,differentmethodsused to loadorga-
nelleswithdyes in culturehaveproducedambiguous results [65].
Based on electron microscopy (EM) analysis of astrocytes in
rodent brain tissue, SLMVs have been suggested as themain sto-
rage compartment for gliotransmitters, including glutamate and
Box 2. EM analysis of astrocytes.
EM has been an essential tool to establish the existence and organization of SVs in neurons. Much less is known about the
organization and distribution of SLMVs in astrocytes in the tissue and about the distribution of astrocytic organelles in gen-
eral. Whereas SVs can be readily identified due to their accumulation in the pre-synapse, SLMVs may be more difficult to find
(see §2c). So far, research has focused on the astrocytic processes that enwrap synapses, from which gliotransmitters are
thought to be released [30]. However, some investigations have suggested that these perisynaptic processes are devoid of
endoplasmic reticulum [50] and sparse in organelles in general (reviewed in [51]), which would question the idea that
they support Ca2þ-regulated exocytosis and gliotransmission [50]. Such a negative conclusion needs to be taken cautiously.
Indeed, almost no study to date has performed a systematic and quantitative ultrastructural analysis of astrocytes, of the dis-
tribution of organelles within astrocytes and of the relationship between astrocytic and neuronal structures. Moreover, and
crucially, good preservation of astrocytes in preparations of the rodent brain using conventional EM methods has not been
sufficiently considered. Indeed, most studies to date have shown that the cytoplasm of astrocytes is electron lucent (‘empty’),
and this feature has even been used as a criterion to identify and distinguish astrocytes from neurons in the neuropil [52,53].
It should be noted, however, that astrocytes and their fine processes do not always appear empty (see figure 2). As discussed
many years ago by Peters et al. [57], astrocytes are certainly not electron lucent but this may be the result of suboptimal tissue
preparation. Astrocytes are in contact through their end-feet with blood vessels and therefore may be prone to volume
changes in poorly fixed preparations [57], which could affect the cytoplasm as well as the distribution of intracellular orga-
nelles. Although the majority of EM studies so far have relied on conventional EM techniques, including chemical fixation
and resin embedding, when other preparations such as high-pressure freezing (HPF) and freeze substitution (FS) [54]
(figure 2a), CEMOVIS [55] (figure 2b) or the Tokuyasu method [58] (figure 2c–e) are used, the appearance of the astrocytic
cytoplasm is similar to that of other cells and organelles can be readily identified, including in the perisynaptic processes.
HPF and FS techniques have been shown in particular to be advantageous in better preserving the morphology of cells
within tissue, including the extracellular space [54]. There may be less fixation-induced osmotic shock and less cell swelling
or shrinkage with this method. Another common EM technique used in cell biology is the Tokuyasu preparation, which has
not been routinely used for brain tissue. The major difference is that the samples are neither fully dehydrated nor embedded
in a resin after fixation and that antigenicity can be preserved. These approaches, together with additional new technologies,
including focused ion beam scanning EM and serial block-face scanning EM will help to analyse astrocytes in three dimen-
sions in large tissue volumes more systematically [59,60] and are expected to provide more advanced and reliable information
on their ultrastructural characteristics.
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5D-serine [66]. In tissue, SLMVs range from30 to80 nmindiameter
andareoften found incloseproximity to theplasmamembrane in
the perisynaptic processes of astrocytes [23,30,66].Whether other
organelles, such as secretory lysosomes and dense core granules
are involved in gliotransmitter release in situ has not been
thoroughly investigated yet.
To further characterize SLMVs, they have been isolated from
astrocytic cultures and investigated biochemically [67,68].
Recent comparison of isolated SLMVs and neuronal SVs has
suggested that astrocytic SLMVs differ from SVs in protein com-
position and transmitter content as well as in the mechanism of
transmitter loading [68].Whereas isolated SVs contained typical
synaptic markers, such as synaptotagmin I and synaptophysin,
SLMVs were negative for those but positive for vGlut2, vesicle-
associated membrane protein (VAMP)2 and VAMP3 as shown
earlier [67,68]. The investigation of isolated SLMVs has further
suggested that they can store D-serine and glutamate in the
same vesicle and co-release them [68]. By contrast, SVs con-
tained glutamate, glycine and GABA but were devoid of
D-serine.Whether SLMVs in vivo can co-release D-serine andglu-
tamate and whether this has specific functional implications
is still unclear as immuno-EM studies have tentatively attribu-
ted the presence of D-serine and glutamate to distinct SLMVs
populations within the same astrocyte [66].
(d) Proteins involved in regulated exocytosis in
astrocytes
Initial studies in cultured astrocytes have found that these
cells express VAMP2 in addition to VAMP3 [15], whichhave focused attention on isolating VAMP2-containing ves-
icles [67,68]. However, more recent immunohistochemistry
studies in tissue have shown that VAMP2 may be weakly
expressed or even not present in mature astrocytes in the
hippocampus [29]. Consistently, the protein was not found
on SLMVs by immuno-EM [30]. Instead, its ubiquitously
expressed homologue VAMP3 has been detected in astrocytes
[29,30]. Interestingly, VAMP3 has been localized to vGlut1-
positive SLMVs in the tissue by EM [30], suggesting that
VAMP3 is important for regulated exocytosis of SLMVs.
This is also consistent with the functional data obtained
with TeNTLC which does not discriminate between VAMP2
and VAMP3. Furthermore, it has been shown that putative
SNARE partners in astrocytes include SNAP23 but not
SNAP25 [15,29,31]. Ca2þ sensitivity of exocytosis is provided
by a Ca2þ sensor protein, whose identity in astrocytes is not
yet known. However, mRNA studies in the tissue have
detected co-expression of several synaptotagmin isoforms in
astrocytes, including either synaptotagmin 7 and 11 or synap-
totagmin 1 and 4 [69]. Synaptotagmin 4 has been reported to
be present on isolated astrocytic vesicles and proposed to be
involved in regulated exocytosis [67,70], although the Ca2þ
sensitivity of synaptotagmin 4 is debated [71].(e) Vesicular transporters found in astrocytes
Transmitter release from a storage compartment requires a
vesicular transport system. In general, astrocytes are thought
to be unable to maintain a high rate of transmitter release as
observed during tetanic trains in neurons due to slower
(a) (b) (e)
(c) (d )
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Figure 2 . Different EM techniques reveal organelles and the dense cytoplasm of astrocytes in the tissue. (a) Using a HPF/FS preparation, it has been shown that
astrocytic processes have a dense and homogeneous cytoplasm. Adapted with permission from [54], (b) Cryo-EM analysis of thin sections of high-pressure frozen
organotypic brain slices shows that astrocytic perisynaptic processes have a dense cytoplasm indistinguishable from the cytoplasm of neurons. Adapted with per-
mission from [55], copyright 2005 National Academy of Sciences, USA, (c– e) Tokuyasu preparation of the GFAP-eGFP mouse [56] labelled with anti-GFP and 15 nm
gold particles (D.A.S. and A.V. 2012, unpublished data). Also in this preparation, the astrocytic cytoplasm is dense and organelles are readily visible; (c) small
astrocytic processes surrounding synapses (S) display dense cytoplasm (astrocytic structures are identified by the presence of GFP and have been highlighted in
green); (d ) organelles are present in the astrocytic cytoplasm; (e) tubular-vesicular structures (indicated by arrows) are present close to the plasma membrane
(PM). As, astrocyte; Ax, axon; Mit, mitochondria; G, golgi complex; MVB, multivesicular body; scale bars: 500 nm. (Online version in colour.)
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6stimulus–secretion coupling. Therefore, a large reserve pool
is not needed in these cells, and a small number of vesicles
(approx. five) per release site may be sufficient. As such,
the transporter levels in astrocytes will be low. The vesicular
transporter for D-serine is not yet known, although a D-serine
transport activity has been recently identified by functional
studies [68]. The transporter for ATP, VNUT, is expressed
in various cell types including astrocytes where it is impor-
tant for release of ATP [39], although the identity of the
compartment in which the transporter is located in situ is
not clearly established. With regard to glutamate, its trans-
porters vGluts1–3 are known to be highly expressed in
neurons. However, astrocytic expression is reported to be
lower, which has led to a debate whether vGluts are function-
ally relevant for glutamate release from astrocytes. Unlike
in neurons, where vGluts are found on all SVs at glutamatergic
terminals, including the large reserve pool (perhaps 100–1000s
vesicles per each synapse), no such accumulation of vesicles is
expected or has been reported in astrocytes so far. Instead, clus-
ters of SLMVs containing 2–15 vesicles each were observed
by EM [66], with a portion of them positive for vGluts [52].
The presence of vGluts in astrocytes has been investigated
in several studies with various experimental approaches.
Endogenous vGlut was detected byWestern blotting or immu-
nohistochemistry in astrocytic cultures, although the staining
pattern varied between preparations [15,28,49,72]. Isolated ves-
icles have been shown to be positive for vGlut2 [67,68]. Various
groups have localized vGluts in tissue, focusing on its astrocy-
tic labelling with opposite results, either observing vGluts in
astrocytes [23,28,30,52, 66,73] or failing to do so [74–76].
VGlut1 was shown by both light microscopy and EM to bepresent in astrocytes in various brain regions [52], although
expression of the transporter in the mouse tissue could be
quite low [52]. This could explain the negative results of
some localization studies relying purely on light microscopy
but not EMobservations [74]. A problemwith lightmicroscopy
is that the vGlut signal in astrocytes may not result in such a
distinct staining pattern as observed in neurons due to a
much smaller number of vesicles and to a different distribution
in comparison to glutamatergic synapses. Moreover, by light
microscopy, attribution of a protein to a distinct cell (astrocyte
versus neuron) in the tissue is challenging if the protein is
located close to the plasma membrane. Other sets of studies
looked at the presence of vGlut transcripts in astrocytes. This
was done, for example, by single-cell reverse transcriptase
PCR. In the adult hippocampus, mRNA transcripts for either
vGlut1 or 2 were detected in subpopulations of S100beta-
positive astrocytes [30]. Gene chip microarray (transcriptome)
analysis of purified astrocytes produced mixed results. One
study reported only very low levels of vGlut transcripts from
the entire forebrain of young mice [77], hence questioning the
existence of glutamate gliotransmission, whereas others
reported higher levels depending on the brain region [78].
These results highlight the importance of investigating astro-
cytes in different anatomical locations and underscore the
heterogeneity of astrocytes due to location, age and species.
( f ) Localization of ion channels releasing
gliotransmitters
Fewer studies have focused on the distribution of ion chan-
nels like Best-1 in different brain regions as well as at the
rstb.royalsocietypublishing.org
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7cellular level. Best-1 is highly expressed in retinal epithelial
cells and at lower levels in skeletal muscle, as well as
kidney, colon and brain [79]. In the brain, Best-1 appears to
be expressed in both neurons and astrocytes [7,80]. In the
hippocampus, Best-1 labelling has also been investigated by
EM [8]. The authors reported that Best-1 is mainly present
at the plasma membrane of the perisynaptic processes that
enwrap synapses, although they also observed an intracellu-
lar pool [8]. These are intriguing results, but they still require
confirmation of the specificity of the Best-1 staining. Indeed,
given that a Best-1 knockout (KO) mouse is available, the
antibodies should be validated on the KO tissue. il.Trans.R.Soc.B
369:201305923. A debated issue: are glutamate levels in
astrocytes too low to support
gliotransmission?
Different from neurons, astrocytes express the cytosolic enzyme
glutamine synthetase (GS), which transforms glutamate into
glutamine, therefore reducing the free cytosolic glutamate
level. While there is consensus that cytosolic glutamate in
tissue astrocytes is lower than in neurons, no reliable measure
of its real concentration exists. It has been proposed that this
reaches ‘housekeeping levels’ and hence it is too low to permit
effective glutamate release from astrocytes ([81], critically
reviewed in [2]), particularly if glutamate would be released
from the cytosol via plasma membrane channels. To verify this
hypothesis, theoretical calculationsweremadebasedon thepro-
portion of immunogold particles labelling L-glutamate in the
cytosol of astrocytes compared with adjacent nerve terminals
in the tissue. According to such calculations, intracellular gluta-
mate in astrocytes should be sufficient to be taken up by vesicles
and exocytosed at concentrations able to activate high-affinity
neuronal receptors such as NMDA receptors [3], even in the
‘worst case’ steady-state conditions. In practice, the situation
could bemore favourable: first, because, once taken up into ves-
icles, glutamate is protected fromconversion toglutaminebyGS
and can be pre-concentrated to relatively high levels; second,
because the interplay betweenuptake of extracellular glutamate,
GS activity, pH changes and GS and vGluts affinities would
favour vesicular uptake. Indeed, conversion of glutamate to glu-
taminebyGS ispHsensitive and is reducedat lower intracellular
pH [82]. At the same time, glutamate uptake into astrocytes is
known to lead to local decrease of intracellular pH, likely by
co-transport of Hþ [83,84]. As a consequence, GS activity
would be slowed down or suppressed [85] and if the local pH
decrease occurs in a sub-membrane domain containing vGlut-
expressing vesicles, as is likely, it is expected to favour vesicular
uptake over conversion of glutamate to glutamine. This uptake
is also favoured because the affinity of vGluts for glutamate
(Km ¼ 1–3 mM [86]) is somewhat higher than that of GS
(approx. 3 mM [87]). In conclusion, the above considerations,
as well as the functional data showing modulatory actions of
astrocytic glutamate on synaptic activity, do not support the
hypothesis that glutamate levels in astrocytes are too low for
effective release of the amino acid.4. Concluding remarks
What do we actually know about gliotransmitter release from
astrocytes? There is clear evidence that astrocytes respond tosynaptic signals with gliotransmitter release. Gliotransmission
has been observed with multiple experimental approaches
from various independent groups [10] and cannot just simply
be an artefact [9].
Two mechanistically different release modes have been
proposed for regulated gliotransmission under physio-
logical conditions: vesicular exocytosis or release via plasma
membrane ion channels. For both, the functional experi-
ments suggest that Ca2þ is the key regulator. Functional
data in tissue based on SNARE-specific toxins and trans-
genic models point towards regulated exocytosis as the
main release mechanism. Morphological observations have
suggested SLMVs as the gliotransmitter storage compart-
ment. Vesicular transporters for glutamate have been
localized to astrocytic SLMVs by EM. However, there is
also evidence for release of GABA and glutamate from the
cytosol through plasma membrane ion channels such as
Best-1, although this is a fairly recent observation and
needs to be further investigated and confirmed by several
laboratories independently.
It is still debated whether astrocytes communicate with
neurons focally or at longer distance via volume transmission.
In support of focal release, both SLMVs and Best-1 channels
have been observed in astrocytic processes juxtaposed to
synapses [8,23,30]. In the peripheral nervous system, a single
glial cell was shown to be able to monitor and modulate two
adjacent synapses independently [88]. Alternatively, volume
transmission relies on diffusion of a transmitter over distance,
which requires the absence of high-affinity uptake systems or
degrading enzymes. In view of this, D-serine and, to some
extent, GABA would be plausible as volume gliotransmitters,
whereas glutamate is less likely to be one. These questions
are yet to be addressed experimentally.
One important debated issue is whether all astrocytes
release the same gliotransmitter(s). At the moment, studies
have been carried out in different brain regions, focusing on
a single type of gliotransmitter at a time. If release of one
gliotransmitter is detected, this does not preclude release
(or even co-release) of another gliotransmitter at the same
time, or under different conditions. In neurons, vesicular
co-release of two neurotransmitters has been reported at the
same synapse. For example, vGlut and vGAT can coexist at
the cerebellar basket cell terminals [89]. Similarly, dopamin-
ergic neurons in nucleus accumbens, but not in dorsal
striatum, can co-release glutamate [90]. Whether this happens
also in astrocytes is not known, although co-transport of
glutamate and D-serine has been reported to occur in isolated
SLMVs [68]. This further raises the question of region speci-
ficity of transporters in astrocytes. Finally, an ion channel,
such as Best-1, could also co-release gliotransmitters,
although this possibility has not been tested yet. More sys-
tematic studies in all brain regions should be carried out for
all gliotransmitters.
Why is there still so much controversy with regard to glio-
transmission and its underlying mechanisms? Certainly,
experiments conducted in different brain regions, at different
ages and using different protocols or even different species
(mouse versus rat) could lead to inherent differences in results.
In order to have a better understanding of gliotransmission,
more rigorous experimental settings, more specific mouse
models, including astrocyte-specific inducible knockouts, and
more selective antagonists for vesicular transporters and chan-
nels are needed. To investigate the protein composition of
rstb.royalsociet
8astrocytic organelles, proteomic analysis could be a useful tool
as has been shown for SVs [91].
In conclusion, much work is still required in order to
understand when, why and how astrocytes release gliotrans-
mitters and, by this process, participate in information
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